← Leaderboards
Kelly Leigh Bolton
Sloan-Kettering Inst Can Research
$3,682,991
Attributed
$3,682,991
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,682,991 · 2
By mechanism
R01$2,488,671 · 1
K08$1,194,320 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Ross L Levine$31,715,816
- Eirini Papapetrou$13,419,805
- Ronglai Shen$3,190,387
- Quathek Querfelli$1,604,594
- Olga A Guryanova$2,670,428
Others in their field
Other Emerging Leaders on “Automobile Driving”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Scott Topper · Broad Institute, Inc.$30,147,501
- Leonard Freedman · Leidos Biomedical Research, Inc.$15,624,898
- Ganesh M Babulal · Washington University$11,062,209
- Christopher A. Gaiteri · Rush University Medical Center$9,886,289
Research focus
Automobile DrivingSamplingPrevention StrategyCohortBiologicalMutationHematopoiesisConstitutionalClinical CareDatabasesAftercareClinical Decision SupportAgedCollectionCharacteristicsClonal ExpansionCancer PatientCancer CareBloodAffectBlood CellsBlood SpecimenBlood TreatmentCancer Survivor
Grant awards (7)
The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease$1,211,984
R01 · FY2025 · AG · contact PI
The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease$1,276,687
R01 · FY2024 · AG · contact PI
Impact of Oncologic Therapy on Clonal Hematopoiesis and Subsequent Risk of Therapy-Related Leukemia$238,864
K08 · FY2023 · CA · contact PI
Impact of Oncologic Therapy on Clonal Hematopoiesis and Subsequent Risk of Therapy-Related Leukemia$238,864
K08 · FY2022 · CA · contact PI
Impact of Oncologic Therapy on Clonal Hematopoiesis and Subsequent Risk of Therapy-Related Leukemia$238,864
K08 · FY2020 · CA · contact PI
Impact of Oncologic Therapy on Clonal Hematopoiesis and Subsequent Risk of Therapy-Related Leukemia$238,864
K08 · FY2020 · CA · contact PI
Impact of Oncologic Therapy on Clonal Hematopoiesis and Subsequent Risk of Therapy-Related Leukemia$238,864
K08 · FY2019 · CA · contact PI